DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia, fetal growth restriction and acute ischemic stroke (AIS) ...

Injections of botulinum toxin, commonly known as Botox, could be an effective and well-tolerated option for treating debilitating complications caused by reduced blood flow to the fingers, such as ...

Medical device firm focused on vascular care Strong revenue growth driven by product demand Broad institutional participation ...

A clinical decision support tool that uses artificial intelligence (AI) to analyze scans after a stroke alongside treatment recommendations is associated with better quality care and long-term ...

A clinical decision support tool that uses artificial intelligence (AI) to analyze scans after a stroke alongside treatment ...

Arch Biopartners announces SM begins patient dosing in phase II CS-AKI trial of LSALT peptide: Toronto Monday, March 23, 2026, 18:00 Hrs [IST] Arch Biopartners Inc. (Arch) announc ...

A 66-year-old male from Nagpur suffering from Acute Ischemic Stroke was successfully treated at Dr. Babasaheb Ambedkar Super Speciality Institute, the - Nagpur News ...

Medtronic (NYSE: MDT) made a significant neurovascular play earlier this month when it agreed to acquire Scientia Vascular.

Rectal bleeding and renal dysfunction in an older patient led to a biopsy that reveals systemic amyloidosis, highlighting a rare gastrointestinal presentation.

Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today that St. Michael’s ...

Medtronic plc (NYSE:MDT) is included among the 14 Quality Stocks with Highest Dividends. On March 10, Medtronic plc (NYSE:MDT ...